Refining the Phenotype of Recurrent Rearrangements of Chromosome 16.
Abnormalities, Multiple
/ classification
Adolescent
Adult
Child
Child, Preschool
Chromosome Aberrations
Chromosome Deletion
Chromosomes, Human, Pair 16
/ genetics
Comparative Genomic Hybridization
DNA Copy Number Variations
/ genetics
Developmental Disabilities
/ classification
Female
Homologous Recombination
/ genetics
Humans
Infant
Infant, Newborn
Karyotype
Male
Phenotype
Segmental Duplications, Genomic
/ genetics
Young Adult
16p11.2 deletions and duplications
16p13.11 deletions and duplications
CNV
array-CGH
chromosome 16
developmental disability
speech disorder
two-hit model
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
04 Mar 2019
04 Mar 2019
Historique:
received:
13
02
2019
revised:
25
02
2019
accepted:
27
02
2019
entrez:
7
3
2019
pubmed:
7
3
2019
medline:
22
6
2019
Statut:
epublish
Résumé
Chromosome 16 is one of the most gene-rich chromosomes of our genome, and 10% of its sequence consists of segmental duplications, which give instability and predisposition to rearrangement by the recurrent mechanism of non-allelic homologous recombination. Microarray technologies have allowed for the analysis of copy number variations (CNVs) that can contribute to the risk of developing complex diseases. By array comparative genomic hybridization (CGH) screening of 1476 patients, we detected 27 cases with CNVs on chromosome 16. We identified four smallest regions of overlapping (SROs): one at 16p13.11 was found in seven patients; one at 16p12.2 was found in four patients; two close SROs at 16p11.2 were found in twelve patients; finally, six patients were found with atypical rearrangements. Although phenotypic variability was observed, we identified a male bias for Childhood Apraxia of Speech associated to 16p11.2 microdeletions. We also reported an elevated frequency of second-site genomic alterations, supporting the model of the second hit to explain the clinical variability associated with CNV syndromes. Our goal was to contribute to the building of a chromosome 16 disease-map based on disease susceptibility regions. The role of the CNVs of chromosome 16 was increasingly made clear in the determination of developmental delay. We also found that in some cases a second-site CNV could explain the phenotypic heterogeneity by a simple additive effect or a pejorative synergistic effect.
Identifiants
pubmed: 30836598
pii: ijms20051095
doi: 10.3390/ijms20051095
pmc: PMC6429492
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Università degli Studi di Milano-Bicocca
ID : 2015-CONT-0089
Organisme : Università degli Studi di Milano-Bicocca
ID : 2016-ATE-0511
Références
Nature. 2004 Dec 23;432(7020):988-94
pubmed: 15616553
J Med Genet. 2006 Feb;43(2):180-6
pubmed: 15980116
Am J Med Genet A. 2005 Dec 15;139(3):231-3
pubmed: 16278905
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17626-31
pubmed: 17101969
Hum Mutat. 2007 Jul;28(7):674-82
pubmed: 17480035
Am J Med Genet A. 2007 Aug 1;143A(15):1679-86
pubmed: 17607705
J Med Genet. 2009 Apr;46(4):223-32
pubmed: 18550696
Eur J Med Genet. 2009 Mar-Jun;52(2-3):77-87
pubmed: 19306953
J Neurosci. 2009 Jul 15;29(28):8884-96
pubmed: 19605626
Nat Genet. 2010 Mar;42(3):203-9
pubmed: 20154674
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9270-4
pubmed: 20439718
Am J Hum Genet. 2010 May 14;86(5):749-64
pubmed: 20466091
Neuron. 2011 Jun 9;70(5):863-85
pubmed: 21658581
PLoS Genet. 2011 Jun;7(6):e1002118
pubmed: 21698135
Nature. 2011 Aug 31;478(7367):97-102
pubmed: 21881559
Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17076-81
pubmed: 21969575
Hum Mutat. 2012 Jun;33(6):906-15
pubmed: 22415865
Genet Med. 2012 Nov;14(11):928-36
pubmed: 22766611
Eur J Hum Genet. 2013 Apr;21(4):455-9
pubmed: 22909774
N Engl J Med. 2012 Oct 4;367(14):1321-31
pubmed: 22970919
PLoS One. 2013;8(3):e58048
pubmed: 23554873
PLoS One. 2013 Apr 18;8(4):e61365
pubmed: 23637818
Biol Psychiatry. 2015 May 1;77(9):785-93
pubmed: 25064419
Schizophr Res. 2014 Nov;159(2-3):340-6
pubmed: 25311781
Eur J Hum Genet. 2016 Feb;24(2):302-6
pubmed: 26173965
J Med Genet. 2016 Feb;53(2):73-90
pubmed: 26502893
JAMA Psychiatry. 2016 Jan;73(1):20-30
pubmed: 26629640
Am J Hum Genet. 2016 Jan 7;98(1):45-57
pubmed: 26749307
Mol Genet Genomics. 2016 Jun;291(3):1443-50
pubmed: 27000657
Mol Autism. 2016 Jun 27;7:30
pubmed: 27354901
Am J Med Genet A. 2016 Nov;170(11):2943-2955
pubmed: 27410714
Nature. 2016 Aug 11;536(7615):205-9
pubmed: 27487209
Sci Rep. 2016 Nov 15;6:36819
pubmed: 27845379
Sci Rep. 2017 Mar 21;7:44446
pubmed: 28322228
Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):367-380
pubmed: 28349640
Neuropsychopharmacology. 2018 Feb;43(3):513-524
pubmed: 28984295